After a long, hard-fought campaign to secure approval for Skyclarys, Cork's Paudie Coady has finally recieved the first dose ...
Leah Alstin used to hide the symptoms of her incurable neurodegenerative disease behind her children’s prams – now the Batesford 43-year-old is rolling through Run4Geelong in her wheelchair and ...
Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high ...
When Design Therapeutics DSGN+0.82%, Inc. (DSGN) reported four-week results for DT-216P2 in May, biotech 865238-0.87% ...
In the crowded history of early twentieth-century neurology, the names that survive in eponyms are usually those of men. Yet one of the most elegant clinical descriptions of a hereditary neurological ...
Charlotte Casey, aged 25, and her 28 year-old sister Olivia Dews suffer from a rare genetic condition called Friedreich’s ...
Higher levels of high-sensitivity cardiac troponin T were independently associated with lower myocardial capillary density in ...
Irish Examiner on MSN
Friedreich’s ataxia patients could yet wait years to receive life-changing drug, group warns
Friedreich’s ataxia patients met with staff from Tallaght Hospital last week who explained the limitations in the current ...
Important research news last week included US biotech Celldex Therapeutics releasing positive Phase III results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results